Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023
Benzinga 在 2023 年 6 月 22 日的最高評級上調、下調
Upgrades
升級
For DiaMedica Therapeutics Inc (NASDAQ:DMAC), Oppenheimer upgraded the previous rating of Perform to Outperform. In the first quarter, DiaMedica Therapeutics showed an EPS of $0.20, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.05 and a 52-week-low of $1.12. DiaMedica Therapeutics closed at $3.64 at the end of the last trading period.
對於 Diamedica Therapeut （納斯達克股票代碼：DMAC），奧本海默將之前的業績評級上調至跑贏大盤。在第一季度，Diamedica Therapeutics的每股收益爲0.20美元，而去年同期爲0.13美元。目前，該股創下52周高點4.05美元，創52周低點1.12美元。Diamedica Therapeutics在上一個交易期末收於3.64美元。
For Kellogg Co (NYSE:K), Bernstein upgraded the previous rating of Underperform to Market Perform. For the first quarter, Kellogg had an EPS of $1.10, compared to year-ago quarter EPS of $1.10. At the moment, the stock has a 52-week-high...
對於 凱洛格公司 （紐約證券交易所代碼：K），伯恩斯坦將先前的表現不佳評級上調至...
登入免費觀看全文
登入/註冊